Audicin, a neurotech startup headquartered in Finland, has closed a US$1.9 million funding round as it scales its nervous system regulation platform.
The raise draws on a mix of private backers, continued support from returning investors Petteri Lahtela and Virpi Tuomivaara, and a grant from Business Finland via its Deep Tech Accelerator programme.
Combined with earlier capital, the company has now secured roughly US$3 million in total funding.
Audicin’s approach sits at the intersection of brainwave entrainment, auditory engineering, and music neuroscience.
Its tools are built to support cognitive focus, stress recovery, sleep quality, and sustained productivity delivered through background audio sessions that respond dynamically to physiological data, keeping the nervous system regulated across the course of a normal day.
Central to its product lineup is Audicin for Apps, a software development kit that embeds regulation protocols directly into third-party digital health, wellness and performance platforms.
The SDK runs quietly in the background, triggered by biometric inputs, time-based cues, or in-app activityand connects natively with popular wearables including Oura, Apple Watch, Garmin, and Whoop, with no additional hardware needed.
Alongside the SDK, Audicin is developing a standalone Sleep Headband built for offline use in connectivity-restricted environments such as hospitals and defence facilities.
The device runs pre-loaded recovery programmes rooted in low-frequency brainwave protocols linked to deep, restorative sleep.
Co-founder and CEO Laura Avonius describes the company’s mission as weaving nervous system support into the fabric of everyday life, removing the need for deliberate user effort while expanding into high-demand settings where performance and recovery are hardest to maintain.
Commercial momentum is building across defence, performance and wellness verticals, with an expanding enterprise pipeline and stronger user engagement following recent product updates.
The new capital will drive commercialisation of the mobile app, Sleep Headband and Audicin for Apps, while funding continued development and entry into new markets.
